Compare ARI & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARI | ENOV |
|---|---|---|
| Founded | 2009 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Fluid Controls |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2009 | 2008 |
| Metric | ARI | ENOV |
|---|---|---|
| Price | $10.74 | $22.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $11.00 | ★ $47.38 |
| AVG Volume (30 Days) | ★ 1.8M | 1.0M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 9.31% | N/A |
| EPS Growth | ★ 183.51 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $271,589,000.00 | N/A |
| Revenue This Year | N/A | $6.36 |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | $67.31 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.49 | $20.55 |
| 52 Week High | $11.24 | $36.82 |
| Indicator | ARI | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 47.73 |
| Support Level | $10.60 | $21.28 |
| Resistance Level | $10.78 | $24.08 |
| Average True Range (ATR) | 0.20 | 1.18 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 31.52 | 38.46 |
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.